Table 2

Carrier frequency comparisons of the different HLA-DRB1 allele groups between rheumatoid arthritis cases and controls in Caucasoid and non-Caucasoid population samples


RA cases, n (%)
Controls, n (%)
OR (95% CI)

S1 alleles



     Caucasoids
125 (29.4%)
183 (41.3%)
0.59 (0.45–0.79)
     Non-Caucasoids
87 (26%)
140 (40%)
0.52 (0.37–0.71)
S2 alleles



     Caucasoids
133 (31%)
66 (15%)
2.61 (1.87–3.64)
     Non-Caucasoids
48 (14%)
37 (11%)
1.40 (0.88–2.21)
S3D alleles



     Caucasoids
123 (29%)
159 (36%)
0.73 (0.55–0.97)
     Non-Caucasoids
112 (33%)
120 (35%)
0.95 (0.69–1.30)
S3P alleles



     Caucasoids
159 (37.5%)
108 (24%)
1.86 (1.39–2.49)
     Non-Caucasoids
170 (51%)
90 (26%)
2.93 (2.12–4.04)
X alleles



     Caucasoids
201 (47%)
244 (55%)
0.74 (0.56–0.96)
     Non-Caucasoids
145 (43%)
192 (55%)
0.61 (0.45–0.83)

The Caucasoid sample population refers to the combination of the following population samples: Greek, Spanish, Russian, and American (Whites). The non-Caucasoid sample population refers to the combination of the following population samples: North American (Amerinds), North American (Blacks), Bushmen, Korean, Chinese, and Javanese. The combined odds ratios (ORs) and 95% confidence intervals (CIs) evaluate the significance of the global effect of the different HLA-DRB1 allele groups on rheumatoid arthritis (RA) susceptibility in Caucasoids and non-Caucasoids.

Barnetche et al. Arthritis Research & Therapy 2008 10:R26   doi:10.1186/ar2379